PNRAX
Price
$60.01
Change
+$0.33 (+0.55%)
Updated
Sep 26 closing price
Net Assets
648.29M
VITSX
Price
$159.28
Change
+$1.00 (+0.63%)
Updated
Sep 26 closing price
Net Assets
1.95T
Interact to see
Advertisement

PNRAX vs VITSX

Header iconPNRAX vs VITSX Comparison
Open Charts PNRAX vs VITSXBanner chart's image
Putnam Research A
Price$60.01
Change+$0.33 (+0.55%)
VolumeN/A
Net Assets648.29M
Vanguard Total Stock Market Idx I
Price$159.28
Change+$1.00 (+0.63%)
VolumeN/A
Net Assets1.95T
PNRAX vs VITSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PNRAX vs. VITSX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PNRAX is a Buy and VITSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.95T vs. PNRAX (648M). VITSX pays higher dividends than PNRAX: VITSX (1.17) vs PNRAX (0.41). PNRAX was incepted earlier than VITSX: PNRAX (30 years) vs VITSX (28 years). PNRAX (1.01) is less costly to investors than VITSX (0.03). PNRAX is a more actively managed with annual turnover of: 35.00 vs. VITSX (2.00). PNRAX has a lower initial minimum investment than VITSX: PNRAX (0) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 15.64 vs. PNRAX (8.65). VITSX return over 5 years is better than : 96.60 vs. PNRAX (71.38).
PNRAXVITSXPNRAX / VITSX
Total Expense Ratio0.890.032,967%
Annual Report Gross Expense Ratio1.010.033,367%
Fund Existence30 years28 years-
Gain YTD13.69812.977106%
Front Load6%N/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets648M1.95T0%
Annual Yield % from dividends0.411.1735%
Returns for 1 year8.6515.6455%
Returns for 3 years70.4680.3288%
Returns for 5 years71.3896.6074%
Returns for 10 years171.56250.7568%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATOS0.860.04
+5.12%
Atossa Therapeutics
RNAZ10.170.25
+2.52%
TransCode Therapeutics Inc
PFGC104.301.30
+1.26%
Performance Food Group Company
ALRS22.620.08
+0.35%
Alerus Financial Corp
TMC6.36-0.20
-3.05%
TMC the metals company